OBI PHARMA - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 86014025
Serial Number
86014025
Registration Number
4737391
Word Mark
OBI PHARMA
Status
700 - Registered
Status Date
2015-05-19
Filing Date
2013-07-18
Registration Number
4737391
Registration Date
2015-05-19
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
090907, 150725, 260126, 261709 - Spinning wheels, looms. Other wheels including vehicular wheels without spokes; hubcaps. Spirals, coils and swirls. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2015-03-03
Attorney Name
Michael T. Smith
Law Office Assigned Location Code
L80
Employee Name
WIENER, MICHAEL A
Statements
Indication of Colors claimed
The color(s) teal and light teal is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMA"
Description of Mark
The mark consists of the letters "OBI", with the letter "O" in teal and light teal and in the form of a spinning wheel, with the letters "BI" in teal. Beneath these letters is a curved line in teal. Beneath the curved line is the term "PHARMA" in teal.
Goods and Services
Antibiotic preparations; Antibiotics; Anti-cancer preparations; Anti-infectives; Anti-inflammatories; Biological preparations for the treatment of cancer; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for medical purposes; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Gastro-intestinal treatment preparations; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for using in oncology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Vaccines
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2013-07-24
Primary Code
005
Current Trademark Owners
Party Name
OBI PHARMA, INC.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
OBI PHARMA, INC.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
OBI PHARMA, INC.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
OBI PHARMA, INC.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Michael T. Smith
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2013-02-05102006969TaiwanTrue
Trademark Events
Event DateEvent Description
2013-07-22NEW APPLICATION ENTERED IN TRAM
2013-07-24NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2013-07-25NOTICE OF DESIGN SEARCH CODE E-MAILED
2013-08-06TEAS VOLUNTARY AMENDMENT RECEIVED
2013-08-07TEAS VOLUNTARY AMENDMENT RECEIVED
2013-08-07TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
2013-10-31ASSIGNED TO EXAMINER
2013-11-06NON-FINAL ACTION WRITTEN
2013-11-06NON-FINAL ACTION E-MAILED
2013-11-06NOTIFICATION OF NON-FINAL ACTION E-MAILED
2014-03-20TEAS RESPONSE TO OFFICE ACTION RECEIVED
2014-03-20CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-03-21TEAS/EMAIL CORRESPONDENCE ENTERED
2014-03-21SUSPENSION LETTER WRITTEN
2014-03-21LETTER OF SUSPENSION E-MAILED
2014-03-21NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2014-06-25TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2014-07-04ASSIGNED TO LIE
2014-07-09CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-07-09TEAS/EMAIL CORRESPONDENCE ENTERED
2014-07-16NON-FINAL ACTION WRITTEN
2014-07-16NON-FINAL ACTION E-MAILED
2014-07-16NOTIFICATION OF NON-FINAL ACTION E-MAILED
2015-01-15TEAS RESPONSE TO OFFICE ACTION RECEIVED
2015-01-15CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-01-15TEAS/EMAIL CORRESPONDENCE ENTERED
2015-01-20APPROVED FOR PUB - PRINCIPAL REGISTER
2015-01-26LAW OFFICE PUBLICATION REVIEW COMPLETED
2015-02-11NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2015-03-03PUBLISHED FOR OPPOSITION
2015-03-03OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2015-05-19REGISTERED-PRINCIPAL REGISTER
2019-05-02TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-05-19COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2021-09-24TEAS SECTION 8 RECEIVED